Navigation Links
Zusetzen von Obinutuzumab (GA101) oder Rituximab zu Chlorambucil verbessert Aussichten für ältere Patienten mit chronischer lymphatischer Leukämie (CLL) und gleichzeitig vorliegenden Erkrankungen (Komorbiditäten)
Date:6/14/2013

STOCKHOLM, June 14, 2013 /PRNewswire/ --

Dr. Valentin Goede wird auf dem 18. Kongress der European Hematology Association in Stockholm vielversprechende Ergebnisse für ältere CLL-Patienten vorstellen.

CLL ist die häufigste Leukämieform in der westlichen Welt. Viele CLL-Patienten sind Senioren mit Komorbiditäten, so dass die aggressiven Standardbehandlungen für sie nicht in Frage kommen. Bislang war ungeklärt, ob (i) eine Kombinationsbehandlung mit dem Chemotherapeutikum Chlorambucil plus einem monoklonalen CD20-Antikörper die Aussichten für diese Patienten gegenüber einer Behandlung mit Chlorambucil allein verbessert und ob (ii) diese Patienten mehr vom Einsatz des neuartigen CD20-Antikörpers Obinutuzumab (GA101) im Vergleich zum zugelassenen CD20-Antikörper Rituximab profitieren.

Die von der Deutschen CLL-Studiengruppe (DCLLSG) in Zusammenarbeit mit Hoffmann-La Roche durchgeführte CLL11-Studie vergleicht erstmals direkt die folgenden Behandlungen für ältere Patienten mit Komorbiditäten: GA101 plus Chlorambucil, Rituximab plus Chlorambucil und Chlorambucil allein.

Das Zusetzen von GA101 oder Rituximab zu Chlorambucil verlängerte die Zeit, in der die Menschen ohne Verschlechterung ihres Zustands lebten (progressionsfreies Überleben), gegenüber Chlorambucil allein wesentlich. Beide Kombinationsbehandlungen zeigten ein akzeptables Sicherheitsprofil für die untersuchte Patientengruppe. Diese Ergebnisse sind ein bedeutender Schritt hin zur Verbesserung der Behandlung älterer CLL-Patienten mit Komorbiditäten (obwohl die Ergebnisse des Direktvergleichs der zwei Antikörper erst zu einem späteren Zeitpunkt der Studie verfügbar sein werden).

Präsentator : Valentin Goede

Zugehörigkeit: Deutsc
'/>"/>

SOURCE European Hematology Association
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Rituximab Promotes Long-Term Response for Patients with Immune Destruction of Platelets
2. Neue klinische Richtlinien für ältere Patienten mit Typ 2 Diabetes, um einen europaweiten Pflegenotstand zu verhindern
3. Een studie in het New England Journal of Medicine bevestigt dat universele dekolonisatie van ic-patiënten voor 44% minder bloedstroominfecties zorgt
4. Studie von Grifols zeigt, dass eine höhere Dosis von PROLASTIN-C den Alpha1-PI-Spiegel in Patienten mit AAT-Mangel in den normalen Bereich anhebt
5. American College of Chest Physicians (ACCP) und Simbionix arbeiten zusammen, um klinische Ausbildung und Patientensicherheit zu verbessern
6. Wie die Operation am echten Patienten - Simulationsausbildung für Gefäßchirurgen und Kardiologen
7. Krebspatienten an neuem Schweizer Zentrum für Strahlentherapie werden mit Elektas fortschrittlichem Versa HD-System behandelt
8. IDEV gibt Ergebnisse von Studie zur Revaskularisation mit Supera an echten Patienten (RESTORE) bekannt - Studie demonstriert positive klinische Ergebnisse bei schwerkranken Patienten mit langen Läsionen
9. Neue europaweite Umfrage Ergibt, dass die Behandlung chronischer Schmerzen bei vielen Patienten unzureichend ist
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/2/2015)... , March 2, 2015   BioLife Solutions ... developer, manufacturer and marketer of proprietary clinical grade ... and precision thermal shipping products for cells ... Seattle Business Magazine has named the Company its 2015 ... Seattle Business Magazine Associate Publisher Michael Romoser ...
(Date:3/2/2015)... March 2, 2015  BioMed Realty Trust, Inc. (NYSE: ... approximately 313,000 square feet of space in the most ... the world through the termination of Vertex Pharmaceuticals, leases ... effective February 28, 2015. BioMed Realty will receive ... immediately begin to reposition the properties to meet the ...
(Date:3/2/2015)... ImmunoCellular Therapeutics, Ltd. ("ImmunoCellular") (NYSE MKT: IMUC) today announced that it ... 2014 on March 9, 2015. The Company also plans to hold ... 2015, at 5:00 pm ET. The call will be hosted by ... , , , LIVE CALL:  , , , (877) ... , , , , , , ...
Breaking Medicine Technology:BioLife Solutions Wins Washington State 2015 Silver Award for Achievement in Medical Technology from Seattle Business Magazine 2BioLife Solutions Wins Washington State 2015 Silver Award for Achievement in Medical Technology from Seattle Business Magazine 3BioMed Realty Gets Back 313,000 Square Feet Of Valuable Real Estate In Cambridge Innovation District 2BioMed Realty Gets Back 313,000 Square Feet Of Valuable Real Estate In Cambridge Innovation District 3ImmunoCellular Therapeutics to Report 2014 Financial Results on March 9, 2015; a Business Update Conference Call and Webcast is Scheduled for March 12, 2015 2
... 2012  Boehringer Ingelheim will present results from LUX-Lung ... investigating afatinib in patients with stage IIIB or ... epidermal growth factor receptor (EGFR) mutation (EGFR M+), ... Society of Clinical Oncology (ASCO) in Chicago, June ...
... May 16, 2012  Leading events organiser UBM Conferences ... announced details of the forthcoming CPhI Extractables and Leachables ... 2pm IST/9:30am GMT/4:30pm CST. The free to attend webinar ... extractables and leachables and during drug development, in addition ...
Cached Medicine Technology:Boehringer Ingelheim to present pivotal Phase III results for afatinib in first-line treatment of EGFR mutation-positive NSCLC at ASCO 2012 2Boehringer Ingelheim to present pivotal Phase III results for afatinib in first-line treatment of EGFR mutation-positive NSCLC at ASCO 2012 3Boehringer Ingelheim to present pivotal Phase III results for afatinib in first-line treatment of EGFR mutation-positive NSCLC at ASCO 2012 4Boehringer Ingelheim to present pivotal Phase III results for afatinib in first-line treatment of EGFR mutation-positive NSCLC at ASCO 2012 5Boehringer Ingelheim to present pivotal Phase III results for afatinib in first-line treatment of EGFR mutation-positive NSCLC at ASCO 2012 6Boehringer Ingelheim to present pivotal Phase III results for afatinib in first-line treatment of EGFR mutation-positive NSCLC at ASCO 2012 7Global Webinar Focuses on Considerations for Extractables and Leachables 2
(Date:3/2/2015)... Hawaii (PRWEB) March 02, 2015 Four Seasons ... is celebrating its 25th anniversary this year, having officially opened ... milestone, the luxury resort is honoring over 70 employees who ... resort -- from amongst the approximately 400 original employees. ... the Resort’s Oceanfront Lawn. , This Four Seasons ...
(Date:3/2/2015)... Regulatory Compliance Associates® Inc. (RCA), ... and technical consulting, announces Mr. Seyed Khorashahi has ... , Before joining RCA, Mr. Khorashahi had over ... all aspects of developing safety-critical medical devices. ... Regulatory Compliance Associates Inc., Baxter Healthcare, and Beckman ...
(Date:3/2/2015)... A true renaissance man—some might call him a “Jack ... band Khazad Doom, has long inspired his countless fans. That ... odds. His motto throughout his life has always been “Got ... before him. And that attitude, born amidst the turmoil and ... a new generation. , As Eadon knows, when you have ...
(Date:3/2/2015)... 02, 2015 In light of the ... Xarelto (rivaroxaban) tablets, Ford & Associates Nationwide ... helpful for future users, but may come too late ... taking the drug. The FDA has now included the ... Reactions on Xarelto's label. The term “cytolytic hepatitis” has ...
(Date:3/2/2015)... March 02, 2015 What are the ... physicians request references? When are interviews scheduled, how can ... opportunities?, Both training and practicing physicians who are looking ... questions and more at the PracticeLink Physician Career Advancement ... drop-in Job Fair is from 5:30 to 8:30 p.m. ...
Breaking Medicine News(10 mins):Health News:Celebrating Four Seasons Resort Maui’s 25th Anniversary 2Health News:Regulatory Compliance Associates® Inc. Welcomes Seyed Khorashahi as Chief Operating Officer 2Health News:Cult Rock Star’s “Got To Make It” Attitude Inspires New Generations 2Health News:Cult Rock Star’s “Got To Make It” Attitude Inspires New Generations 3Health News:Ford & Associates Nationwide Legal Services, A.P.C., Comments on Xarelto Lawsuits Upon FDA Revisions 2Health News:Ford & Associates Nationwide Legal Services, A.P.C., Comments on Xarelto Lawsuits Upon FDA Revisions 3Health News:Ford & Associates Nationwide Legal Services, A.P.C., Comments on Xarelto Lawsuits Upon FDA Revisions 4Health News:PracticeLink to Host a Career Advancement Workshop and Job Fair in Houston 2
... minutes of vigorous activity a week , , THURSDAY, Dec. ... people in the United States last year met the ... of those people met the Healthy People 2010 physical ... , According to the 2008 guidelines, released in ...
... Ga., Dec. 4 Aflac Incorporated,(NYSE: AFL ... at the Goldman,Sachs U.S. Financial Services Conference 2008. ... Aflac Incorporated, and he is,scheduled to make a presentation ... Aflac Incorporated presentation, Mr. Cloninger will discuss the,company,s outlook ...
... Offers Strategies to Manage Stress and Promote Health during Holidays , ... -- As reports about the extent of the recession in ... the American Psychological Association (APA) finds that more than eight out ... crisis is impacting women and families most. , ...
... nerve problem best diagnosed with combination of assessments, researchers ... combination of blood tests and other specialized assessments seems ... a common nerve problem called neuropathy, according to new ... , Neuropathy, which affects one in 50 people in ...
... for sickle cell disease and thalassemia , , THURSDAY, ... a gene mutation that inhibits the production of ... sickle cell disease and thalassemia. , The finding ... restore some hemoglobin production, turning these life-threatening diseases ...
... Commander of The American Legion Department of Indiana has released ... VA Medical Center: , , ... Indiana, more than 120,000 war time veterans, are following the ... Center with dismay and keen interest. , ...
Cached Medicine News:Health News:Almost Two-Thirds of Americans Meet Exercise Guidelines 2Health News:Almost Two-Thirds of Americans Meet Exercise Guidelines 3Health News:Aflac Incorporated To Present at the Goldman Sachs U.S. Financial Services Conference 2008 2Health News:Financial Concerns Top List of Holiday Stressors for Women, Families with Children 2Health News:Financial Concerns Top List of Holiday Stressors for Women, Families with Children 3Health News:Financial Concerns Top List of Holiday Stressors for Women, Families with Children 4Health News:Doctors Issue New Neuropathy Test Guidelines 2Health News:Gene Behind Childhood Anemias Found 2Health News:Gene Behind Childhood Anemias Found 3Health News:American Legion, Department of Indiana Releases Statement Concerning Revelations of Illicit Drug Trafficking at Roudebush VA Medical Center 2
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: